William Ding, MD
Radiation Oncology · Bloomfield, NJNPI 1982845608
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $525 of the $653 with a category attached, or 80.4%. Myriad Genetic Laboratories, Inc. accounts for 80.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $350 and has fallen 91.3% since, to $31 in 2025.
Across 9 payments — averaging $72.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$525
- Bayer$48
- Boston Scientific$31
- Johnson & Johnson$21
- Myovant Sciences Inc.$14
- AstraZeneca$14
What the payments were for
- Consulting fees$52580%
- Food & beverage$12820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 2 | $525 |
| Bayer | 3 | $48 |
| Boston Scientific | 1 | $31 |
| Johnson & Johnson | 1 | $21 |
| Myovant Sciences Inc. | 1 | $14 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolaris$525
How this compares
$653 in reported general payments places this provider in the 55th percentile of 132 radiation oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 87 | $801 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Bloomfield
- Michael GreenbergCherry Hill$335K
- Glen GejermanHackensack$180K
- Marc RudoltzWest Orange$166K
- Salma JabbourNew Brunswick$163K
- Edward SoffenMonroe Twp$50K
- Adnan DanishWayne$45K
- Timothy ChenPennington$43K
- Brett LewisHackensack$23K
- Sang SimLong Branch$16K
- Thomas KoleMiddletown$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.